abemaciclibribociclibpalbociclibfulvestrantanastrozoleletrozolebreast cancerRegional University Hospital of Málagaendocrine therapy
…have doubled progression-free survival. Approved agents include abemaciclib, palbociclib, and ribociclib. In the MONARCH 2 trial, abemacicl…